CV Sciences, Inc. (CVSI)
- Previous Close
0.0475 - Open
0.0475 - Bid 0.0451 x --
- Ask 0.0474 x --
- Day's Range
0.0475 - 0.0475 - 52 Week Range
0.0300 - 0.1000 - Volume
10,000 - Avg. Volume
219,870 - Market Cap (intraday)
9.033M - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Nov 12, 2024 - Nov 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
www.cvsciences.com42
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CVSI
View MorePerformance Overview: CVSI
Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CVSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CVSI
View MoreValuation Measures
Market Cap
8.38M
Enterprise Value
8.40M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.47
Price/Book (mrq)
3.34
Enterprise Value/Revenue
0.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.95%
Return on Assets (ttm)
-12.51%
Return on Equity (ttm)
-78.97%
Revenue (ttm)
15.85M
Net Income Avi to Common (ttm)
-2.53M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
477k
Total Debt/Equity (mrq)
19.78%
Levered Free Cash Flow (ttm)
-112.75k
Research Analysis: CVSI
View MoreCompany Insights: CVSI
CVSI does not have Company Insights